Xometry (NASDAQ:XMTR) Price Target Raised to $70.00

Xometry (NASDAQ:XMTR) had its target price lifted by JPMorgan Chase & Co. from $55.00 to $70.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other research firms have also recently weighed in on XMTR. Cantor Fitzgerald raised their price target on Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a report on Wednesday. UBS Group increased their target price on Xometry from $35.00 to $40.00 and gave the company a “neutral” rating in a research report on Wednesday, August 6th. Citizens Jmp boosted their price target on shares of Xometry from $65.00 to $75.00 and gave the stock a “market outperform” rating in a research report on Wednesday. Citigroup reaffirmed an “outperform” rating on shares of Xometry in a research note on Wednesday. Finally, Wedbush lifted their price objective on shares of Xometry from $48.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Xometry currently has a consensus rating of “Hold” and a consensus price target of $57.89.

Xometry Stock Performance

Shares of NASDAQ XMTR opened at $64.81 on Wednesday. The company has a market cap of $3.29 billion, a P/E ratio of -51.85 and a beta of 0.87. Xometry has a 52-week low of $18.59 and a 52-week high of $65.08. The company has a debt-to-equity ratio of 1.20, a quick ratio of 3.85 and a current ratio of 3.62. The firm’s fifty day moving average is $51.82 and its two-hundred day moving average is $40.87.

Xometry (NASDAQ:XMTR) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. Xometry had a negative net margin of 9.80% and a negative return on equity of 6.59%. The business had revenue of $180.72 million during the quarter, compared to the consensus estimate of $168.25 million. During the same quarter in the prior year, the firm earned $0.02 EPS. The business’s revenue was up 27.5% on a year-over-year basis. Xometry has set its Q4 2025 guidance at EPS. As a group, analysts anticipate that Xometry will post -0.66 EPS for the current fiscal year.

Insider Buying and Selling at Xometry

In related news, CFO James Miln sold 598 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $50.25, for a total transaction of $30,049.50. Following the transaction, the chief financial officer directly owned 144,115 shares in the company, valued at approximately $7,241,778.75. This represents a 0.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Randolph Altschuler sold 9,331 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $50.31, for a total transaction of $469,442.61. Following the completion of the sale, the chief executive officer directly owned 310,271 shares in the company, valued at $15,609,734.01. This trade represents a 2.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 9.66% of the company’s stock.

Institutional Investors Weigh In On Xometry

Several hedge funds and other institutional investors have recently modified their holdings of XMTR. GAMMA Investing LLC lifted its stake in shares of Xometry by 160.1% during the 1st quarter. GAMMA Investing LLC now owns 1,004 shares of the company’s stock worth $25,000 after acquiring an additional 618 shares during the last quarter. Principal Financial Group Inc. grew its position in Xometry by 242.3% in the 1st quarter. Principal Financial Group Inc. now owns 100,903 shares of the company’s stock valued at $2,515,000 after acquiring an additional 71,425 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Xometry by 6.1% in the first quarter. Bank of New York Mellon Corp now owns 116,295 shares of the company’s stock worth $2,898,000 after purchasing an additional 6,690 shares during the period. Cerity Partners LLC lifted its position in shares of Xometry by 1.2% during the first quarter. Cerity Partners LLC now owns 135,088 shares of the company’s stock worth $3,366,000 after purchasing an additional 1,548 shares during the last quarter. Finally, New York State Common Retirement Fund boosted its stake in shares of Xometry by 4.4% during the first quarter. New York State Common Retirement Fund now owns 942,088 shares of the company’s stock valued at $23,477,000 after purchasing an additional 39,480 shares during the period. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.